Signia Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Signia Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2.5M	Sell	314,432 -46,189	-13%	-$477K	4.5%	11
2020 Q1	$3.13M	Sell	360,621 -120,779	-25%	-$1.26M	6.69%	3
2019 Q4	$5.45M	Buy	481,400 +35,807	+8%	+$381K	5.29%	6
2019 Q3	$4.84M	Buy	445,593 +76,526	+21%	+$833K	5.4%	4
2019 Q2	$3.46M	Buy	369,067 +103,034	+39%	+$1.04M	4.31%	11
2019 Q1	$3.27M	Buy	266,033 +54,890	+26%	+$670K	3.96%	13
2018 Q4	$2.5M	Buy	+211,143	New	+$2.9M	2.9%	18
2016 Q2	–	Sell	-22,549	Closed	-$237K	–	34
2016 Q1	$237K	Buy	22,549 +521	+2%	+$5.72K	0.67%	33
2015 Q4	$261K	Sell	22,028 -304	-1%	-$3.73K	0.81%	32
2015 Q3	$261K	Sell	22,332 -3,637	-14%	-$48.2K	0.86%	27
2015 Q2	$375K	Buy	+25,969	New	+$375K	0.98%	30

Other funds holding LFCR

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Signia Capital Management's LFCR Position: Q2 2020 in Review

Signia Capital Management reduced its Lifecore Biomedical (LFCR) stake by 13% in Q2 2020, selling an estimated $477K and leaving 314,432 shares worth $2.5M. The position accounts for 4.5% of the portfolio, ranked #11.

Signia Capital Management first reported a position in LFCR in Q2 2015 and has held it in 11 quarters since. The position peaked at $5.45M in Q4 2019. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2020.

Signia Capital Management held 314,432 shares of Lifecore Biomedical worth $2.5M as of Q2 2020.
Signia Capital Management sold 46,189 Lifecore Biomedical shares in Q2 2020, an estimated $477K.
Lifecore Biomedical made up 4.5% of Signia Capital Management's portfolio in Q2 2020, its #11 holding.
Signia Capital Management first reported a position in Lifecore Biomedical in Q2 2015 and has held it in 11 quarters since.
Signia Capital Management's Lifecore Biomedical position peaked at $5.45M in Q4 2019.
95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2020.

Based on Signia Capital Management's 13F filing for Q2 2020, filed 10 Aug 2020.